Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oral immunotherapy (OIT) is not a single molecule or receptor, but rather a therapeutic approach that targets the immune system to induce tolerance to specific food allergens. The process involves administering gradually increasing amounts of an allergenic food under medical supervision, with the goal of desensitizing the immune response and allowing individuals with food allergies to tolerate exposure without severe reactions.
Desensitization via effector cell suppression; induction/modulation of regulatory pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune System (Oral Immunotherapy) (N/A).